000 01781 a2200493 4500
005 20250515053937.0
264 0 _c20070913
008 200709s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/sj.bjc.6603579
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aForget, M-A
245 0 0 _aThe Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types.
_h[electronic resource]
260 _bBritish journal of cancer
_cFeb 2007
300 _a646-53 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents, Hormonal
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aFemale
650 0 4 _aGene Expression Profiling
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aIntercellular Signaling Peptides and Proteins
_xbiosynthesis
650 0 4 _aKidney Neoplasms
_xgenetics
650 0 4 _aLung Neoplasms
_xgenetics
650 0 4 _aMale
650 0 4 _aMelanoma
_xgenetics
650 0 4 _aPlacenta
_xmetabolism
650 0 4 _aProstatic Neoplasms
_xgenetics
650 0 4 _aRNA, Messenger
_xanalysis
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
_xmethods
650 0 4 _aSensitivity and Specificity
700 1 _aTurcotte, S
700 1 _aBeauseigle, D
700 1 _aGodin-Ethier, J
700 1 _aPelletier, S
700 1 _aMartin, J
700 1 _aTanguay, S
700 1 _aLapointe, R
773 0 _tBritish journal of cancer
_gvol. 96
_gno. 4
_gp. 646-53
856 4 0 _uhttps://doi.org/10.1038/sj.bjc.6603579
_zAvailable from publisher's website
999 _c16808499
_d16808499